725 related articles for article (PubMed ID: 9769330)
1. The negative inotropic effect of beta3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle.
Gauthier C; Leblais V; Kobzik L; Trochu JN; Khandoudi N; Bril A; Balligand JL; Le Marec H
J Clin Invest; 1998 Oct; 102(7):1377-84. PubMed ID: 9769330
[TBL] [Abstract][Full Text] [Related]
2. Altered contractile response due to increased beta3-adrenoceptor stimulation in diabetic cardiomyopathy: the role of nitric oxide synthase 1-derived nitric oxide.
Amour J; Loyer X; Le Guen M; Mabrouk N; David JS; Camors E; Carusio N; Vivien B; Andriantsitohaina R; Heymes C; Riou B
Anesthesiology; 2007 Sep; 107(3):452-60. PubMed ID: 17721248
[TBL] [Abstract][Full Text] [Related]
3. Beta3-adrenoceptor in the eel (Anguilla anguilla) heart: negative inotropy and NO-cGMP-dependent mechanism.
Imbrogno S; Angelone T; Adamo C; Pulerà E; Tota B; Cerra MC
J Exp Biol; 2006 Dec; 209(Pt 24):4966-73. PubMed ID: 17142685
[TBL] [Abstract][Full Text] [Related]
4. Endothelial beta3-adrenoceptors mediate vasorelaxation of human coronary microarteries through nitric oxide and endothelium-dependent hyperpolarization.
Dessy C; Moniotte S; Ghisdal P; Havaux X; Noirhomme P; Balligand JL
Circulation; 2004 Aug; 110(8):948-54. PubMed ID: 15302798
[TBL] [Abstract][Full Text] [Related]
5. Involvement of beta 3-adrenoceptor in altered beta-adrenergic response in senescent heart: role of nitric oxide synthase 1-derived nitric oxide.
Birenbaum A; Tesse A; Loyer X; Michelet P; Andriantsitohaina R; Heymes C; Riou B; Amour J
Anesthesiology; 2008 Dec; 109(6):1045-53. PubMed ID: 19034101
[TBL] [Abstract][Full Text] [Related]
6. Effects of the beta3-adrenergic agonist BRL 37344 on endothelial nitric oxide synthase phosphorylation and force of contraction in human failing myocardium.
Napp A; Brixius K; Pott C; Ziskoven C; Boelck B; Mehlhorn U; Schwinger RH; Bloch W
J Card Fail; 2009 Feb; 15(1):57-67. PubMed ID: 19181295
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of beta- but not alpha 1-mediated adrenergic responses in isolated hearts and cardiomyocytes by nitric oxide and 8-bromo cyclic GMP.
Ebihara Y; Karmazyn M
Cardiovasc Res; 1996 Sep; 32(3):622-9. PubMed ID: 8881523
[TBL] [Abstract][Full Text] [Related]
8. Functional beta3-adrenoceptor in the human heart.
Gauthier C; Tavernier G; Charpentier F; Langin D; Le Marec H
J Clin Invest; 1996 Jul; 98(2):556-62. PubMed ID: 8755668
[TBL] [Abstract][Full Text] [Related]
9. Role of nitric oxide/cyclic GMP and cyclic AMP in beta3 adrenoceptor-chronotropic response.
Sterin-Borda L; Bernabeo G; Ganzinelli S; Joensen L; Borda E
J Mol Cell Cardiol; 2006 Apr; 40(4):580-8. PubMed ID: 16510153
[TBL] [Abstract][Full Text] [Related]
10. The preferential beta3-adrenoceptor agonist BRL 37344 increases force via beta1-/beta2-adrenoceptors and induces endothelial nitric oxide synthase via beta3-adrenoceptors in human atrial myocardium.
Pott C; Brixius K; Bundkirchen A; Bölck B; Bloch W; Steinritz D; Mehlhorn U; Schwinger RH
Br J Pharmacol; 2003 Feb; 138(3):521-9. PubMed ID: 12569077
[TBL] [Abstract][Full Text] [Related]
11. Beta3-adrenergic eNOS stimulation in left ventricular murine myocardium.
Brixius K; Bloch W; Ziskoven C; Bölck B; Napp A; Pott C; Steinritz D; Jiminez M; Addicks K; Giacobino JP; Schwinger RH
Can J Physiol Pharmacol; 2006 Oct; 84(10):1051-60. PubMed ID: 17328145
[TBL] [Abstract][Full Text] [Related]
12. Effect of clenbuterol on non-endothelial nitric oxide release in rat mesenteric arteries and the involvement of beta-adrenoceptors.
Marín J; Balfagón G
Br J Pharmacol; 1998 Jun; 124(3):473-8. PubMed ID: 9647470
[TBL] [Abstract][Full Text] [Related]
13. Beta3-adrenoceptors modulate left ventricular relaxation in the rat heart via the NO-cGMP-PKG pathway.
Angelone T; Filice E; Quintieri AM; Imbrogno S; Recchia A; Pulerà E; Mannarino C; Pellegrino D; Cerra MC
Acta Physiol (Oxf); 2008 Jul; 193(3):229-39. PubMed ID: 18208582
[TBL] [Abstract][Full Text] [Related]
14. Beta 3-adrenoceptor stimulation induces vasorelaxation mediated essentially by endothelium-derived nitric oxide in rat thoracic aorta.
Trochu JN; Leblais V; Rautureau Y; Bévérelli F; Le Marec H; Berdeaux A; Gauthier C
Br J Pharmacol; 1999 Sep; 128(1):69-76. PubMed ID: 10498836
[TBL] [Abstract][Full Text] [Related]
15. Enhanced inhibition of L-type Ca2+ current by beta3-adrenergic stimulation in failing rat heart.
Zhang ZS; Cheng HJ; Onishi K; Ohte N; Wannenburg T; Cheng CP
J Pharmacol Exp Ther; 2005 Dec; 315(3):1203-11. PubMed ID: 16135702
[TBL] [Abstract][Full Text] [Related]
16. Expression, activity and functional significance of inducible nitric oxide synthase in the failing human heart.
Drexler H; Kästner S; Strobel A; Studer R; Brodde OE; Hasenfuss G
J Am Coll Cardiol; 1998 Oct; 32(4):955-63. PubMed ID: 9768717
[TBL] [Abstract][Full Text] [Related]
17. Muscarinic and beta-adrenergic regulation of heart rate, force of contraction and calcium current is preserved in mice lacking endothelial nitric oxide synthase.
Vandecasteele G; Eschenhagen T; Scholz H; Stein B; Verde I; Fischmeister R
Nat Med; 1999 Mar; 5(3):331-4. PubMed ID: 10086391
[TBL] [Abstract][Full Text] [Related]
18. Nebivolol, a vasodilating selective beta(1)-blocker, is a beta(3)-adrenoceptor agonist in the nonfailing transplanted human heart.
Rozec B; Erfanian M; Laurent K; Trochu JN; Gauthier C
J Am Coll Cardiol; 2009 Apr; 53(17):1532-8. PubMed ID: 19389564
[TBL] [Abstract][Full Text] [Related]
19. Control of cardiac muscle cell function by an endogenous nitric oxide signaling system.
Balligand JL; Kelly RA; Marsden PA; Smith TW; Michel T
Proc Natl Acad Sci U S A; 1993 Jan; 90(1):347-51. PubMed ID: 7678347
[TBL] [Abstract][Full Text] [Related]
20. Role of nitric oxide in beta3-adrenoceptor activation on basal tone of internal anal sphincter.
Banwait KS; Rattan S
Am J Physiol Gastrointest Liver Physiol; 2003 Sep; 285(3):G547-55. PubMed ID: 12736154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]